ABSTRACT

Conclusion:

The results indicate that niclosamide induces apoptosis and suppresses cell proliferation by inhibiting Wnt/β-catenin signaling pathway in OVCAR-3 cells. In conclusion, these findings warrant further evaluation of niclosamide as a promising therapy for ovarian cancer.

Results:

It was found that niclosamide at 1 μM and 2 μM concentrations reduced cell viability, whereas 5-FU showed its significant proliferation inhibitory effect at higher concentrations. Niclosamide led to an increase in apoptosis while this effect was weaker compared with 5-FU. Niclosamide treatment decreased β-catenin staining in the cells significantly but 5-FU did not affect β-catenin levels.

Methods:

MTT assay was applied to investigate the cytotoxic effects of niclosamide on the cells. β-catenin levels in the cells were analyzed by immunocytochemistry, in order to assess the potency of niclosamide on Wnt/β-catenin signaling pathway that function in cell proliferation. The effects of the drug on apoptosis were detected by TUNEL method. All the assays were also performed for chemotherapy agent 5-fluorouracil (5-FU) and anticancer effects of these two drugs were compared.

Objective:

The aim of this study is to investigate in vitro effects of an antihelminthic drug niclosamide on human ovarian carcinoma cell line OVCAR- 3.